跳至主要内容
临床试验/NCT03581227
NCT03581227已完成不适用

The CAPTURE Study: Validating a Unique Chronic Obstructive Pulmonary Disease (COPD) Case Finding Tool in Primary Care

Weill Medical College of Cornell University8 个研究点 分布在 1 个国家目标入组 4,679 人开始时间: 2018年10月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,679
试验地点
8
主要终点
Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant COPD at baseline

研究概览

简要总结

A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.

详细描述

The CAPTURE tool consists of a 5-item self-administered questionnaire and selected use of peak expiratory flow (PEF) measurement, designed to identify clinically significant COPD.

For Aim 1 approximately 5,000 patients will be recruited across 100 participating primary care clinics. Eligible participants will undergo a baseline visit during which the CAPTURE tool and PEF will be obtained, as well as spirometry and other participant characteristics.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
45 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Provision of signed and dated informed consent form
  • •Stated willingness to comply with all study procedures and availability for the duration of the study
  • •Male or female, aged 45-80 years

排除标准

  • •Previous clinician provided diagnosis of COPD
  • •Treated respiratory infection (with antibiotics and/or systemic steroids) in the past 30 days of baseline
  • •Participants unable to perform spirometry due to any of the following conditions within the past 30 days of baseline
  • •Chest surgery
  • •Abdominal surgery
  • •Eye surgery
  • •Heart attack

结局指标

主要结局

Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant COPD at baseline

时间窗: Baseline

Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant COPD at baseline. Clinically significant COPD is defined as participants with abnormal spirometry, defined as post-bronchodilator FEV1/FVC \< 0.7, plus one of the following: FEV1 \< 60% predicted, or ≥ 1 exacerbation-like event within the past 12 months. If a participant is unable to complete a post-bronchodilator spirometry (refusal, technical error on the part of coordinator, etc.), and the pre-bronchodilator FEV1/FVC is less than 0.65, the participant will be considered to have COPD for the purpose of follow-up in this study.

次要结局

  • Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with spirometrically defined COPD at baseline(Baseline)
  • Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with mild COPD at baseline(Baseline)
  • Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant COPD across sex, ethnic groups, urban vs rural location, and educational status.(Baseline)
  • Positive and negative predictive values (PPV and NPV) in different practice settings(Baseline)
  • Areas under the receiving operator characteristic curve (AUC) for various cutpoints of CAPTURE and PEF (Peak expiratory flow) measurements to determine the best cutpoint for mild COPD screen(Baseline)
  • Areas under the receiving operator characteristic curve (AUC) for various cutpoints of CAPTURE and PEF (Peak expiratory flow) measurements to determine the best cutpoint for clinically significant COPD screen(Baseline)
  • AUC to identify the combination of patient/site characteristics which best discriminates those with clinically significant COPD(Baseline)
  • Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with spirometrically defined COPD across sex, ethnic groups, urban vs rural location, and educational status.(Baseline)
  • Areas under the receiving operator characteristic curve (AUC) for various cutpoints of CAPTURE and PEF (Peak expiratory flow) measurements to determine the best cutpoint for spirometrically defined COPD screen(Baseline)
  • AUC to identify the combination of patient/site characteristics which best discriminates those with mild COPD(Baseline)
  • AUC to identify the combination of patient/site characteristics which best discriminates those with spirometrically defined COPD(Baseline)
  • Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with mild COPD across sex, ethnic groups, urban vs rural location, and educational status.(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验